EDMONTON, ALBERTA--(Marketwire - October 24, 2007) - Ceapro Inc. (TSX VENTURE: CZO) With epidemic increases in the incidence of diabetes - most of which can be prevented - early and regular testing for glucose intolerance is now easier and more pleasant. Ceapro proudly joins the fight against diabetes with CeaProve® screening technology and will have a booth at the Canadian Diabetes Association (CDA)/Canadian Society of Endocrinology and Metabolism (CSEM) Professional Conference, taking place October 24-27 in Vancouver.